Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Quality of life and drug compliance: their interrelationship in rheumatic patients

L. Hromadkova, T. Soukup, J. Vlcek,

. 2015 ; 21 (5) : 919-24. [pub] 20150617

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc16020667

RATIONALE, AIMS AND OBJECTIVES: In rheumatic disorders, one of the treatment objectives is to improve the patient's quality of life (QoL). Similar to other chronic conditions, drug compliance is poor, but necessary for successful treatment. The relationship between drug compliance and QoL has never been tested. The aim of this study was to elucidate the relationship between drug compliance and QoL in patients with different rheumatic disorders. METHOD: A cross-sectional study was conducted and patients ≥18 years of age with rheumatoid arthritis (RA), spondyloarthritis (SA), juvenile idiopathic arthritis (JIA) and systemic scleroderma (SSc) were recruited. Data were collected by questionnaires including the Short Form 36 version 2, Compliance Questionnaire Rheumatology (CQR), Health Assessment Questionnaire and by a general questionnaire that focused on demographic characteristics. RESULTS: The questionnaires were completed by 289 patients. Of the respondents, 61.6% (178) were treated for RA, 16.3% (47) for SA, 14.2% (41) for SSc and 8% (23) for JIA. The median of CQR score ranged from 66.7 (JIA) to 82.5 (RA), with 51.6% of patients reaching a score <80. QoL was decreased mainly in the physical component, with the lowest rate for patients with SSc. Higher compliance was observed in patients with decreased QoL (physical component), nevertheless, statistical significance of the relationship was reached only in JIA and SA patients. CONCLUSION: Doctors caring for rheumatic patients should focus their efforts on strengthening drug compliance in patients with higher QoL where it seems that lower compliance is more likely.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16020667
003      
CZ-PrNML
005      
20160729100811.0
007      
ta
008      
160722s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/jep.12399 $2 doi
024    7_
$a 10.1111/jep.12399 $2 doi
035    __
$a (PubMed)26083391
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hromadkova, Lucie $u Department of Clinical Pharmacy, Hospital Na Homolce, Prague, Czech Republic. Hospital Pharmacy, Masaryk Hospital, Usti nad Labem, Czech Republic.
245    10
$a Quality of life and drug compliance: their interrelationship in rheumatic patients / $c L. Hromadkova, T. Soukup, J. Vlcek,
520    9_
$a RATIONALE, AIMS AND OBJECTIVES: In rheumatic disorders, one of the treatment objectives is to improve the patient's quality of life (QoL). Similar to other chronic conditions, drug compliance is poor, but necessary for successful treatment. The relationship between drug compliance and QoL has never been tested. The aim of this study was to elucidate the relationship between drug compliance and QoL in patients with different rheumatic disorders. METHOD: A cross-sectional study was conducted and patients ≥18 years of age with rheumatoid arthritis (RA), spondyloarthritis (SA), juvenile idiopathic arthritis (JIA) and systemic scleroderma (SSc) were recruited. Data were collected by questionnaires including the Short Form 36 version 2, Compliance Questionnaire Rheumatology (CQR), Health Assessment Questionnaire and by a general questionnaire that focused on demographic characteristics. RESULTS: The questionnaires were completed by 289 patients. Of the respondents, 61.6% (178) were treated for RA, 16.3% (47) for SA, 14.2% (41) for SSc and 8% (23) for JIA. The median of CQR score ranged from 66.7 (JIA) to 82.5 (RA), with 51.6% of patients reaching a score <80. QoL was decreased mainly in the physical component, with the lowest rate for patients with SSc. Higher compliance was observed in patients with decreased QoL (physical component), nevertheless, statistical significance of the relationship was reached only in JIA and SA patients. CONCLUSION: Doctors caring for rheumatic patients should focus their efforts on strengthening drug compliance in patients with higher QoL where it seems that lower compliance is more likely.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a juvenilní artritida $x farmakoterapie $x psychologie $7 D001171
650    _2
$a revmatoidní artritida $x farmakoterapie $x psychologie $7 D001172
650    _2
$a průřezové studie $7 D003430
650    _2
$a posuzování pracovní neschopnosti $7 D004185
650    _2
$a stupeň vzdělání $7 D004522
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a adherence k farmakoterapii $x statistika a číselné údaje $7 D055118
650    _2
$a lidé středního věku $7 D008875
650    12
$a kvalita života $7 D011788
650    _2
$a revmatické nemoci $x farmakoterapie $x psychologie $7 D012216
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a spondylartritida $x farmakoterapie $x psychologie $7 D025241
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Soukup, Tomas $u 2nd Department of Internal Medicine - Gastroenterology, University Hospital and Faculty of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic.
700    1_
$a Vlcek, Jiri $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University in Prague, Hradec Kralove, Czech Republic.
773    0_
$w MED00006122 $t Journal of evaluation in clinical practice $x 1365-2753 $g Roč. 21, č. 5 (2015), s. 919-24
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26083391 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20160729101034 $b ABA008
999    __
$a ok $b bmc $g 1155337 $s 945195
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 21 $c 5 $d 919-24 $e 20150617 $i 1365-2753 $m Journal of evaluation in clinical practice $n J Eval Clin Pract $x MED00006122
LZP    __
$a Pubmed-20160722

Find record

Citation metrics

Archiving options